TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Gamma-aminobutyric acid (GABA) Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving Seroconversion Against Influenza Vaccine Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants Reporting Serious Adverse Events (SAEs) And Adverse Events of Special Interest (AESI)
Endpoint domain: Adverse events/effects
Primary endpoint: Penn Shoulder Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Severe adverse device effects or serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Correlation between HOVR and Ankle Brachial Index (ABI) and Toe Brachial Index (TBI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Release of brain injury biomarkers (NFL and GFAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 2-year locoregional survival outcomes
Endpoint domain: Mortality/survival
Primary endpoint: Serious adverse event (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of successful discontinuation of immunosuppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conscious detection threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment-related sperm parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: treatment-related sperm epimutation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: treatment-related plasma testosterone and THC/THC metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change from baseline in the MDS-UPDRS Part III
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline in SpO2/FiO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hand Activity Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menstrual Healthy Living Behaviors Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality of Life Visual Analog Scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Alzheimer's disease severity assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression assessment in elderly
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Oxygen saturation SpO2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Family Planning Attitude
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Immunogenicity index of GMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rhodes Index of Nausea, Vomiting, and Retching
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Communication apprehension
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of visceral branch patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Incidence of endoleak
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of re-operation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in WMC skills assessment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Efficacy of Maraviroc in COVID-19 patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of addiction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants with treatment related toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Histological response after neoadjuvant ADG106 + chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of low blood sugar events overnight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency and severity of Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximal systolic acceleration (ACCmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intraoperative Complication Rates
Endpoint domain: Adverse events/effects
Primary endpoint: 30-Day Post-Operative Complication Rates
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Physical activity on Actigraph GT9X accelerometers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported physical activity on IPAQ-sf
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cancer-related quality of life on EORTC QLQ-C30 and EORTC-BR23
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Viral shedding time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of the participants who have progression of COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Occurrence of incident second IMID
Endpoint domain: Adverse events/effects
Primary endpoint: Useful Field of View (UFOV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of midface and lower face
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in omega-3 polyunsaturated fatty acid (n-3 PUFA) blood levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Ratio of immune biomarker production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tregs count (% CD4+)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Th17 count (% CD3+)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tregs to Th17 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Local field potentiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Single neural spikes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in scores on Behavior Assessment System for Children (BASC-3)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in scores on Child Behavior Checklist (CBCL)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Muscle relaxation recovery index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of same day discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Adequacy for diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective drainage of pleural effusion and pneumothorax
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Outcome of therapeutic effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of CIM
Endpoint domain: Mortality/survival
Primary endpoint: Pain during TMJ arthrocentesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebrovascular reactivity (CVR) by BOLD-fMRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Bi-Weekly prevalence of groin problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Severity Outcome
Endpoint domain: Adverse events/effects
Primary endpoint: Complete regression of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Radial Bias from the Crowding Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from Baseline Saccadic Precision
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from Baseline Fixation Stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in pain intensity of migraine attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Height measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic Respiratory Disease Questionnaire (CDRQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Weight in kilogrammes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AMH assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Meibomian gland dropout percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported average pain intensity for the previous week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported back-related function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in retinal sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anatomical changes using structural optical coherence tomography (OCT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total opioid consumption in 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of colonisation with non-toxigenic C. difficile
Endpoint domain: Adverse events/effects
Primary endpoint: Initial Pain outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional status outcomes using the Western Ontario and McMaster University Arthritis Index (WOMAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional status outcome using the Timed up and go (TUG) test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived difficulties of test execution
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reaction and movement speed and attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Serum Brain-derived neurotrophic factor (BDNF) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Diaphragm electrical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days of opioid use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change from baseline 3D computed tomography data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline X-ray apical film data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tissue Section Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Off-bed time (days)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drainage amount (ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Donor site acute complication (< 30 days)
Endpoint domain: Adverse events/effects
Primary endpoint: Temperament and Character Inventory
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ego Resilience Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Subjective Well-being
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Self-Compassion Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive performance difference
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Physical performance difference
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cmax of RPL554
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of RPL554
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax of RPL554
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: t1/2 of RPL554
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urine citrate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of Grade 3 or Grade 4 toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Negative nasal screening rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Parental Readiness for Hospital Discharge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Richmond Agitation and Sedation Scale (RASS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postpartum Bonding Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Paternal Role Significance Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: 1-year hospital readmission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: High Systolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to shelter exit
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Inflammatory markers quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immune profile characterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Resolution of the papillary edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: conversion resection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Systemic Level of Diclofenac after a single dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic Level of Diclofenac after three doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal Fluid levels of Diclofenac after three doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal Fluid levels of Diclofenac after a single dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with abnormal vaginal exam findings
Endpoint domain: Adverse events/effects
Primary endpoint: Major cardiac or respiratory events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline Muscular fitness at 2 months: The trunk muscle strength/endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline Muscular fitness at 5 months: The trunk muscle strength/endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline Muscular fitness at 2 months: lower body strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline Muscular fitness at 5 months: lower body strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline Muscular fitness at 2 months: upper body strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Prevalence of skin intolerance (eczema symptoms)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Fluctuation in body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HbA1c Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetes Knowledge Level
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Collagen architecture of the breast
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Living conditions of children with Autism Spectrum Disorders (ASD)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: level of awareness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Survey Completion Rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Type, incidence, severity and attribution of AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma concentration of D-0120 and Allopurinol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Therapy Motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: number of captured episodes with freezing of gait (FOG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of captured steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: difference between the pressure of steps with left versus right foot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TNF Alpha levels in Tear Film
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Feasibility to disseminate the mychoice tool to patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Staged Procedure Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temperature of Scapular Region
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events (AEs) and Serious AEs (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Signs of intolerance
Endpoint domain: Adverse events/effects
Primary endpoint: Subject sensitivity to SS-POR11
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the drug concentration-time curve (AUC0-last)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lung Clearance Index Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: rate of complications/morbidities
Endpoint domain: Adverse events/effects
Primary endpoint: rate of complete resection (CR) in group 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: rate of procedures completed by laparoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time-to-event to achieve WHO level ≤3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All-Cause Mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Lactate Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rating of Perceived Exertion (RPE)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Maximal sustained mean power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with serious outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: EMG onset of multifidus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: EMG duration of multifidus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: EMG duration of transversus abdominus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: EMG onset of transversus abdominus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: EMG onset of gluteus medius
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Visual Analogical Scale (VAS) for radiculalgia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain numeric scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: short form of 36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Innate Immunological Markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Pulmonary pulsatility index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in serum levels of inflammatory biomarkers (Leptin, IL-6, TNF-α)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: sensitivity and specificity of imaging techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Leicester Cough Questionnaire (LCQ) score at 1 week post-treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline visual analogue cough severity score at 1 week post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Polyp Recurrence Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: compassion fatigue
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Inpatient Participant Pain Rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Outpatient Participant Pain Rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Inpatient Participant Mobility Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes